1. Antibodies to the endoplasmic reticulum-resident chaperones calnexin, BiP and Grp94 in patients with rheumatoid arthritis and systemic lupus erythematosus. (9th March 2010) Authors: Weber, C K; Haslbeck, M; Englbrecht, M; Sehnert, B; Mielenz, D; Graef, D; Distler, J H; Burkhardt, H; Schett, G; Voll, R E; Fürnrohr, B G Journal: Annals of the rheumatic diseases Issue: Volume 69(2010)Supplement 2 Page Start: A10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. HMGB1 containing nucleosomes from apoptotic cells induce inflammation and immune activation via TLR2 – implications for the etiopathogenesis of systemic lupus erythematosus. (9th March 2010) Authors: Urbonaviciute, V; Fürnrohr, B G; Meister, S; Munoz, L; Heyder, P; De Marchis, F; Bianchi, M E; Kirschning, C; Wagner, H; Manfredi, A A; Kalden, J R; Schett, G; Rovere-Querini, P; Herrmann, M; Voll, R E Journal: Annals of the rheumatic diseases Issue: Volume 69(2010)Supplement 2 Page Start: A1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. IgG autoantibodies bound to surfaces of necrotic cells and complement C4 comprise the phagocytosis promoting activity for necrotic cells of systemic lupus erythaematosus sera. Issue 11 (28th December 2007) Authors: Grossmayer, G E; Munoz, L E; Weber, C K; Franz, S; Voll, R E; Kern, P M; Kalden, J R; Schett, G; Herrmann, M; Gaipl, U S Journal: Annals of the rheumatic diseases Issue: Volume 67:Issue 11(2008) Page Start: 1626 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Loading of nuclear autoantigens prototypically recognized by systemic lupus erythematosus sera into late apoptotic vesicles requires intact microtubules and myosin light chain kinase activity. (26th November 2014) Authors: Zirngibl, M; Fürnrohr, B G; Janko, C; Munoz, L E; Voll, R E; Gregory, C D; Schett, G; Herrmann, M Journal: Clinical and experimental immunology Issue: Volume 179:Number 1(2015:Jan.) Page Start: 39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Proteasome inhibition aggravates tumour necrosis factor-mediated bone resorption. (9th March 2010) Authors: Kireva, T; Polzer, K; Neubert, K; Meister, S; Frey, B; Baum, W; Distler, J H; Schett, G; Voll, R E; Zwerina, J Journal: Annals of the rheumatic diseases Issue: Volume 69(2010)Supplement 2 Page Start: A16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Refractory SLE patients respond to the proteasome inhibitor bortezomib. (22nd February 2012) Authors: Hiepe, F; Alexander, T; Peukert, R; Rubbert, A; Rech, J; Braun, T; Schott, G; Wiesener, M; Eckardt, K U; Baeuerle, M; Reisch, A; Hoyer, B; Taddeo, A; Burmester, G; Schett, G; Radbruch, A; Voll, R E Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 1 Page Start: A15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The early marginal zone B cell initiated T independent type 2 response resists the proteasome inhibitor bortezomib. (9th March 2010) Authors: Lang, V; Mielenz, D; Jäck, H Martin; Neubert, K; Böhm, C; Schett, G; Voll, R E; Meister, S Journal: Annals of the rheumatic diseases Issue: Volume 69(2010)Supplement 2 Page Start: A12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗